T-cell activation involves two phases, enabling a more precise immune response. This insight may boost cancer immunotherapy ...

UVA researchers discover distinct immune changes in Long COVID survivors, offering hope for targeted therapies.

Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited tumor-infiltrating lymphocytes (TILs) may be ...

2025 — A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

There were, however, important differences in their immune responses, results show. For example, hunter/killer T cells in ...

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...

T cells are essential components of the immune system and play critical roles in immune responses against infections, tumors, and autoimmune diseases ...

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Emerging research highlights how vitamin D boosts immunity and reduces colorectal cancer (CRC) risk by regulating ...